ABACUS TPN Calculation Software recalled for medication error risk
Baxter Healthcare's ABACUS TPN calculation software poses a potential risk of medication error. The FDA issued a Class I recall; healthcare providers should contact the manufacturer for guidance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4. The recall addresses a potential risk of medication error in a drug delivery and calculation system, which could cause serious patient harm.
Plain-English summary
ABACUS TPN (Total Parenteral Nutrition) Calculation software is manufactured by Baxter Healthcare Corporation and is used with ExactaMix automated compounding devices to calculate formulations for parenteral nutrition preparations. Multiple software versions are affected, including versions 3.1, 3.2, and 3.3.
The FDA has classified this as a Class I recall due to a potential risk of medication error when using the software. Medication errors in parenteral nutrition calculations could result in serious health consequences for patients.
This recall affects 9 units distributed internationally, including the United States (including Puerto Rico), Canada, Argentina, Chile, Colombia, Bermuda, Dominican Republic, Panama, Vietnam, Hong Kong, Singapore, and EMEA regions.
Healthcare providers using ABACUS TPN software should contact Baxter Healthcare Corporation or consult FDA guidance regarding this recall. Healthcare facilities should review their use of affected software versions and follow manufacturer guidance for any corrections or updates.
The recalled product
- Product
- ABACUS TPN (Total Parenteral Nutrition) Calculation software, Product codes: 8300-0167 (Abacus V3.1 CE), 8300-0168 (Abacus V3.1 SE), 8300-0169 (Abacus V3.1 ME), 8300-0191 (Abacus V3.2 CE), 8300-0192 (Abacus V3.2 SE), 8300-0193 (Abacus V3.2 ME), 8300-3391 (Abacus V3.3 CE), 8300-3
- Manufacturer
- Baxter Healthcare Corporation
- Hazard
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Product Code 8300-3391
- UDI (01)05413765577345(10)3.3.2.1
- Release date 20-Sep-2019
- Product Code 8300-3392
- UDI (01)05413765577352(10)3.3.2.1
- Product Code 8300-3393
- UDI (01)05413765577369(10)3.3.2.1
- Product Codes: 8300-0167
- V3.1 CE
- Release date 20-May-2013
- 8300-0168
- V3.1 SE
- 8300-0169
- V3.1 ME
- 8300-0191
- V3.2 CE
- Release date 17-Dec-2015
- 8300-0192
- V3.2 SE
- 8300-0193
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- CriticalBaxter Recalls Sodium Chloride Injection Bags Due to Fiberglass Particulates
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Same hazard · medication error
See all →- HighIV Administration Sets from Windstone Medical for Infusion Pump Systems
FDA (Devices) · 2026-04-29
- HighMedline Industries IV Administration and Extension Sets Recalled Due to Potential Leaks
FDA (Devices) · 2026-02-25
- HighBD Pyxis Medication Dispensing Systems Software Sync Error Recall
FDA (Devices) · 2025-03-26
- ModeratePrescription statin LIVALO tablets recalled due to foreign tablets in bottles
FDA (Drugs) · 2025-03-19
- HighPyxis Medication and Anesthesia Dispensing Systems Recalled for Software Vulnerabilities
FDA (Devices) · 2025-02-19